ERBB2 and breast cancer: Olavs Hospital in Trondheim, Norway, and used surrogate markers applied to tissue microarrays of archival tumour tissue to determine the following molecular subtypes: Luminal A, Luminal B (HER2-), Luminal B (HER2+), and the non-luminal subtypes, the HER2 type and TN breast cancer.